{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "epsTrailingTwelveMonths": -0.02, "sharesOutstanding": 98269600, "fiftyDayAverage": 0.212132, "fiftyDayAverageChange": -0.035532013, "fiftyDayAverageChangePercent": -0.16749954, "twoHundredDayAverage": 0.1948015, "twoHundredDayAverageChange": -0.0182015, "twoHundredDayAverageChangePercent": -0.093436144, "marketCap": 22225462, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "currency": "EUR", "financialCurrency": "SEK", "regularMarketOpen": 0.177, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.034999996, "fiftyTwoWeekLowChangePercent": 0.24717511, "fiftyTwoWeekRange": "0.1416 - 0.2605", "fiftyTwoWeekHighChange": -0.08390002, "fiftyTwoWeekHighChangePercent": -0.32207298, "fiftyTwoWeekLow": 0.1416, "fiftyTwoWeekHigh": 0.2605, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "firstTradeDateMilliseconds": 1532325600000, "priceHint": 4, "marketState": "REGULAR", "regularMarketChange": 0.002399996, "regularMarketTime": 1683892037, "regularMarketDayHigh": 0.184, "regularMarketDayRange": "0.1766 - 0.184", "regularMarketDayLow": 0.1766, "regularMarketVolume": 80, "regularMarketPreviousClose": 0.1742, "bid": 0.0, "ask": 0.0, "fullExchangeName": "Frankfurt", "regularMarketChangePercent": 1.3777244, "regularMarketPrice": 0.1766, "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "exchange": "FRA", "shortName": "MOBERG PHARMA AB", "longName": "Moberg Pharma AB (publ)", "messageBoardId": "finmb_35248832", "market": "dr_market", "symbol": "MB8A.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "GustavslundsvAegen 42", "address2": "5th Floor", "city": "Bromma", "zip": "167 51", "country": "Sweden", "phone": "46 8 52 23 07 00", "fax": "46 87 35 20 29", "website": "https://www.mobergpharma.se", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products in Europe, the United States, and internationally. It develops MOB-015, which has completed Phase III clinical trial for the treatment of nail fungus. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was incorporated in 2006 and is headquartered in Bromma, Sweden.", "fullTimeEmployees": 7, "companyOfficers": [{"maxAge": 1, "name": "Ms. Kerstin Valinder Strinnholm", "age": 62, "title": "Independent Exec. Chairman", "yearBorn": 1960, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Anna  Ljung BA, M.Sc.", "age": 42, "title": "Chief Exec. Officer", "yearBorn": 1980, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Marie  Moberg", "title": "Co-Founder", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Mark  Beveridge", "age": 44, "title": "VP of Fin.", "yearBorn": 1978, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Gunilla  Wengstr\u00f6m", "title": "Sr. Director of Sales & Marketing", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Anders  Broijersen M.D., Ph.D.", "age": 58, "title": "Chief Medical Officer", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Jesper  Lind", "age": 62, "title": "Head of Supply", "yearBorn": 1960, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Agneta  Larhed", "age": 58, "title": "VP of Pharmaceutical Innovation & Devel.", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}